Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$4.51 - $11.75 $138,447 - $360,701
-30,698 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$13.03 - $17.0 $399,994 - $521,866
30,698 New
30,698 $515,000

Others Institutions Holding VACC

About Vaccitech plc


  • Ticker VACC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,216,200
  • Market Cap $127M
  • Description
  • Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B...
More about VACC
Track This Portfolio

Track Arena Capital Advisors, Llc Ca Portfolio

Follow Arena Capital Advisors, Llc Ca and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arena Capital Advisors, Llc Ca, based on Form 13F filings with the SEC.

News

Stay updated on Arena Capital Advisors, Llc Ca with notifications on news.